# A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

> **NCT04898348** · PHASE2 · WITHDRAWN · sponsor: **KoBioLabs**

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** KBL697
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04898348
- **Lead sponsor:** KoBioLabs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-14
- **Primary completion:** 2023-07-28
- **Final completion:** 2023-07-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients recruited
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898348, "A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04898348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*